Stay updated with breaking news from Deteriorating Disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FASENRA enabled patients to taper off oral corticosteroids while preventing relapses ...
23.02.2024 - Positive results from the MANDARA Phase III trial for FASENRA (benralizumab) in patients with EGPA were published in the New England Journal of Medicine today,1 as the first head-to-head trial of biologics in patients with EGPA,2 and the first to ...
First head-to-head trial of biologics in EGPA, comparing a single monthly injection of FASENRA to three injections per month of mepolizumab ...